MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis

OBJECTIVES: To provide an integrated analysis of major adverse cardiovascular events (MACEs) and events of venous thromboembolism (VTE) and associated risk factors across rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS) phase 2b/3 upadacitinib clinical programmes...

Descripción completa

Detalles Bibliográficos
Autores principales: Charles-Schoeman, Christina, Choy, Ernest, McInnes, Iain B, Mysler, Eduardo, Nash, Peter, Yamaoka, Kunihiro, Lippe, Ralph, Khan, Nasser, Shmagel, Anna K, Palac, Hannah, Suboticki, Jessica, Curtis, Jeffrey R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Inflammatory Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649869/
https://www.ncbi.nlm.nih.gov/pubmed/37945286
http://dx.doi.org/10.1136/rmdopen-2023-003392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649869/
https://www.ncbi.nlm.nih.gov/pubmed/37945286
http://dx.doi.org/10.1136/rmdopen-2023-003392

Ejemplares similares